Peptech launches dog contraceptive
Thursday, 09 December, 2004
Peptech Animal Health, a wholly owned subsidiary of Sydney-based Peptech (ASX:PTD) has begun to market its slow-release canine contraceptive, Suprelorin, to Australian veterinarians.
The Suprelorin implant is is inserted under the skin between the dog's shoulders . It contains an active ingredient, deslorelin, which causes temporary sterility and suppresses sexual behaviour by inactivating the pituitary-gland receptors for the master signalling molecule, gonadoptrophin-releasing hormone (GnRH). This reduces testosterone levels to zero.
"Castration is widely recommended in Australia and New Zealand, for good health and behavioural reasons," said Peptech Animal Health managing director, Dr Tim Trigg.
"Suprelorin provides the advantages of castration, without resorting to surgery."
Peptech Animal Health recently received an Australian Research Committee (ARC) linkage grant to investigate the use of Suprelorin in controlling large marsupial populations, including koala and kangaroo.
Victoria detects H5N1 avian influenza strain
It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
